Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence; PDUFA date set for July 23, 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|MRK||Community voting in process|
Slingshot Insights Explained
Don’t see a project related to the catalyst you care about?